Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 178

1.

(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.

Breeman WA, de Blois E, Sze Chan H, Konijnenberg M, Kwekkeboom DJ, Krenning EP.

Semin Nucl Med. 2011 Jul;41(4):314-21. doi: 10.1053/j.semnuclmed.2011.02.001. Review.

PMID:
21624565
2.

In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.

Niedermoser S, Chin J, Wängler C, Kostikov A, Bernard-Gauthier V, Vogler N, Soucy JP, McEwan AJ, Schirrmacher R, Wängler B.

J Nucl Med. 2015 Jul;56(7):1100-5. doi: 10.2967/jnumed.114.149583. Epub 2015 May 14.

3.
4.

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.

Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP.

Endocr Relat Cancer. 2010 Jan 29;17(1):R53-73. doi: 10.1677/ERC-09-0078. Print 2010 Mar. Review.

5.

68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy.

Gabriel M, Oberauer A, Dobrozemsky G, Decristoforo C, Putzer D, Kendler D, Uprimny C, Kovacs P, Bale R, Virgolini IJ.

J Nucl Med. 2009 Sep;50(9):1427-34. doi: 10.2967/jnumed.108.053421. Epub 2009 Aug 18.

6.

Clinical applications of Gallium-68.

Banerjee SR, Pomper MG.

Appl Radiat Isot. 2013 Jun;76:2-13. doi: 10.1016/j.apradiso.2013.01.039. Epub 2013 Feb 20. Review.

7.

Validation of (68)Ge/(68)Ga generator processing by chemical purification for routine clinical application of (68)Ga-DOTATOC.

Asti M, De Pietri G, Fraternali A, Grassi E, Sghedoni R, Fioroni F, Roesch F, Versari A, Salvo D.

Nucl Med Biol. 2008 Aug;35(6):721-4. doi: 10.1016/j.nucmedbio.2008.04.006. Epub 2008 Jun 17.

PMID:
18678358
8.

The untapped potential of Gallium 68-PET: the next wave of ⁶⁸Ga-agents.

Smith DL, Breeman WA, Sims-Mourtada J.

Appl Radiat Isot. 2013 Jun;76:14-23. doi: 10.1016/j.apradiso.2012.10.014. Epub 2012 Oct 29.

PMID:
23232184
9.

Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.

de Blois E, Sze Chan H, Naidoo C, Prince D, Krenning EP, Breeman WA.

Appl Radiat Isot. 2011 Feb;69(2):308-15. doi: 10.1016/j.apradiso.2010.11.015. Epub 2010 Nov 23.

PMID:
21145751
10.

Dosimetry of [⁶⁸Ga]-labeled compounds.

Eberlein U, Lassmann M.

Appl Radiat Isot. 2013 Jun;76:70-4. doi: 10.1016/j.apradiso.2012.06.033. Epub 2012 Jul 20. Review.

PMID:
22884623
11.

68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.

Fani M, André JP, Maecke HR.

Contrast Media Mol Imaging. 2008 Mar-Apr;3(2):67-77. doi: 10.1002/cmmi.232. Review.

PMID:
18383558
12.
13.

Development of single vial kits for preparation of (68)Ga-labelled peptides for PET imaging of neuroendocrine tumours.

Mukherjee A, Pandey U, Chakravarty R, Sarma HD, Dash A.

Mol Imaging Biol. 2014 Aug;16(4):550-7. doi: 10.1007/s11307-014-0719-2.

PMID:
24477930
14.

(68)Ga-labeled peptides in tumor imaging.

Maecke HR, Hofmann M, Haberkorn U.

J Nucl Med. 2005 Jan;46 Suppl 1:172S-8S. Review.

15.

Past, present and future of 68Ge/68Ga generators.

Rösch F.

Appl Radiat Isot. 2013 Jun;76:24-30. doi: 10.1016/j.apradiso.2012.10.012. Epub 2012 Nov 22.

PMID:
23245638
16.

Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.

Poeppel TD, Binse I, Petersenn S, Lahner H, Schott M, Antoch G, Brandau W, Bockisch A, Boy C.

Recent Results Cancer Res. 2013;194:353-71. doi: 10.1007/978-3-642-27994-2_18.

PMID:
22918768
17.

Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.

Henze M, Schuhmacher J, Dimitrakopoulou-Strauss A, Strauss LG, Mäcke HR, Eisenhut M, Haberkorn U.

Eur J Nucl Med Mol Imaging. 2004 Mar;31(3):466. Epub 2004 Jan 17. No abstract available.

PMID:
14730407
18.

A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion.

Sharma V, Sivapackiam J, Harpstrite SE, Prior JL, Gu H, Rath NP, Piwnica-Worms D.

PLoS One. 2014 Oct 29;9(10):e109361. doi: 10.1371/journal.pone.0109361. eCollection 2014.

19.

68Ga-DOTA-peptides in the diagnosis of NET.

Ambrosini V, Fanti S.

PET Clin. 2014 Jan;9(1):37-42. doi: 10.1016/j.cpet.2013.08.007. Epub 2013 Sep 14. Review.

PMID:
25029932
20.

68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT.

Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, Kovacs P, Von Guggenberg E, Bale R, Virgolini IJ.

J Nucl Med. 2007 Apr;48(4):508-18.

Supplemental Content

Support Center